Pipeline - Notch Therapeutics

PRODUCT DEVELOPMENT PIPELINE.

Notch’s pipeline has the potential to serve large numbers of patients with safe and effective therapies.

Our CD19 + CD20 CAR UNi-T product for B-cell non-Hodgkin lymphoma and autoimmune indications is at the Preclinical / Proof of Concept stage, with two more oncology products in Discovery, including our DLL3 CAR product for small-cell lung cancer. Notch is also partnered with Allogene Therapeutics to develop allogeneic iPSC-derived T cell therapies, and is well suited to support additional partnering opportunities.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others